Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and BCG Trained Immunity in Fungal Infection
NCT06628544Phase 1Completed
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Sep 2020
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of metformin in fungal infection and Tuberculosis (TB) (5 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoints: Interleukin-6 and Transforming Growth Factor-alpha. Started Sep 2020; status: completed.
02
Drugs
metformin
03
Conditions
fungal infectionTuberculosis (TB)
Beyond the preview
Go deeper on NCT06628544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06628544.